Vascular Closure

Rapid hemostasis for arterial and venous access sites
Our portfolio of vascular closure products provides rapid hemostasis for interventional and electrophysiology procedures to help clinicians reduce the risk of complications, improve patient satisfaction, and enable same day discharge.

Optimizing Vascular Access Management
• Enables same day discharge following AF ablation with VASCADE MVP^® and VASCADE MVP^® XL venous vascular closure systems (VVCS)
• Reduces the risk of access site complications with VASCADE^® vascular closure system (VCS), as demonstrated in the RESPECT Clinical Trial¹
• VASCADE family offers an outcomes-based risk-sharing VASCADE Performance Guarantee program – Sharing Risk by Sharing Costs^™

VASCADE®

The only closure device proven safer than manual compression in a randomized clinical trial with zero major complications.^1,2

Learn More

VASCADE MVP®

Elegantly simple and easy to use, with 0% major complications in >1,000 patients in 5 EP clinical trials.^3-7

Learn More

VASCADE MVP® XL

Now with an expanded indication for 10-14F inner diameter (17F max outer diameter) sheaths. Simply Bigger with 58% more collagen and a 9% larger disc compared to VASCADE MVP®.⁸

Learn More

Same Day Discharge

Read the latest clinical publications.

Learn More

Fellows Development

An educational forum for Electrophysiology, Interventional Cardiology, Interventional Radiology, and Vascular Surgery fellows to increase their awareness and share best practices related to vascular closure. Our goal is to help fellows hone their vascular closure skills.

Learn More

Same Day Discharge

Electrophysiologists across the nation are achieving early ambulation and implementing same day discharge programs using the VASCADE MVP^® and VASCADE MVP^® XL systems. Read the latest clinical publications and hear from other EP physicians in our Same Day Discharge webinars and presentations.

1. Hermiller JB., et al. A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients. J Invasive Cardiol. 2015; 27(3): 129-36.
2. Data for the chart is from U.S. FDA IFUs and includes both Interventional and Diagnostic treatment arms. All Intention To Treat patients and events are included in the chart. As complication rate data are based on a cross-trial comparison and not head-to-head clinical trials, the data may not be directly comparable due to differences in study protocols, conditions and patient populations.
3. Complication rates for manual compression presented are based on the composite of manual compression complication rates included in the IFUs of the devices presented.
4. Please consult product labels and instructions for use for indications, contraindications, warnings, precautions and adverse events. See VASCADE^® EU IFU 5685 Instructions for Use.

COL-COPY-002256-US(AD)

Connect with us

Not all products are available in all markets.